{"title":"脊柱转移患者的后部可逆性脑病综合征","authors":"Jin Wook Kim, J. Jeong","doi":"10.32587/JNIC.2018.00024","DOIUrl":null,"url":null,"abstract":"Corresponding Author: Ju Ho Jeong, M.D., Ph.D. Department of Neurosurgery, Dongguk University Gyeongju Hospital, Dongguk University College of Medicine, 87 Dongdaero, Gyeongju 38067, Korea Tel: +82-54-770-8232 Fax: +82-54-770-8378 E-mail: ktokhou@gmail.com Posterior reversible encephalopathy syndrome (PRES), also named reversible posterior leukoencephalopathy, is not a familiar term to neurosurgeon. The PRES is characterized by various kinds of neurologic signs and symptoms that include headache, seizure, altered mental status, lethalgy, visual loss and focal neurological disability. A 63-year-old female visited with upper back pain and both leg weakness. She has been receiving chemotherapy with gemcitabine and cisplatin for lung cancer with multiple bone metastasis. According to the imaging, we diagnosed the patient as T8 pathologic fracture. Five days after surgical decompression, she suddenly complained of visual loss. Magnetic resonance imaging(MRI) of the brain showed bilateral subcortical and cortical edema in the parieto-occipital area. Her MRI finding and symptoms suggested the PRES. Five days after conservative treatment, her visual disturbance was completely recovered. We believe that accurate and early detection of PRES and adequate treatment is very important for the patient having a history of chemotherapy.","PeriodicalId":356321,"journal":{"name":"Journal of Neurointensive Care","volume":"4 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Posterior Reversible Encephalopathy Syndrome in a Patient with Spinal Metastasis\",\"authors\":\"Jin Wook Kim, J. Jeong\",\"doi\":\"10.32587/JNIC.2018.00024\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Corresponding Author: Ju Ho Jeong, M.D., Ph.D. Department of Neurosurgery, Dongguk University Gyeongju Hospital, Dongguk University College of Medicine, 87 Dongdaero, Gyeongju 38067, Korea Tel: +82-54-770-8232 Fax: +82-54-770-8378 E-mail: ktokhou@gmail.com Posterior reversible encephalopathy syndrome (PRES), also named reversible posterior leukoencephalopathy, is not a familiar term to neurosurgeon. The PRES is characterized by various kinds of neurologic signs and symptoms that include headache, seizure, altered mental status, lethalgy, visual loss and focal neurological disability. A 63-year-old female visited with upper back pain and both leg weakness. She has been receiving chemotherapy with gemcitabine and cisplatin for lung cancer with multiple bone metastasis. According to the imaging, we diagnosed the patient as T8 pathologic fracture. Five days after surgical decompression, she suddenly complained of visual loss. Magnetic resonance imaging(MRI) of the brain showed bilateral subcortical and cortical edema in the parieto-occipital area. Her MRI finding and symptoms suggested the PRES. Five days after conservative treatment, her visual disturbance was completely recovered. We believe that accurate and early detection of PRES and adequate treatment is very important for the patient having a history of chemotherapy.\",\"PeriodicalId\":356321,\"journal\":{\"name\":\"Journal of Neurointensive Care\",\"volume\":\"4 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-10-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Neurointensive Care\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.32587/JNIC.2018.00024\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neurointensive Care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32587/JNIC.2018.00024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
通讯作者:Ju Ho Jeong, M.D, Ph.D.韩国庆州38067东大路87号东国大学医学院东国大学庆州医院神经外科电话:+82-54-770-8232传真:+82-54-770-8378 E-mail: ktokhou@gmail.com后部可逆性脑病综合征(PRES),也称为可逆性后部白质脑病,是神经外科医生不熟悉的术语。PRES的特点是各种神经系统体征和症状,包括头痛、癫痫发作、精神状态改变、嗜睡、视力丧失和局灶性神经功能障碍。一名63岁女性因上背部疼痛和双腿无力就诊。她一直在接受吉西他滨和顺铂化疗肺癌多发性骨转移。根据影像学检查,我们诊断患者为T8病理性骨折。手术减压5天后,她突然抱怨视力下降。脑磁共振成像(MRI)显示双侧皮质下和皮质水肿在顶枕区。经保守治疗5天后,患者视力障碍完全恢复。我们认为,对于有化疗史的患者来说,准确、早期发现PRES和适当的治疗是非常重要的。
Posterior Reversible Encephalopathy Syndrome in a Patient with Spinal Metastasis
Corresponding Author: Ju Ho Jeong, M.D., Ph.D. Department of Neurosurgery, Dongguk University Gyeongju Hospital, Dongguk University College of Medicine, 87 Dongdaero, Gyeongju 38067, Korea Tel: +82-54-770-8232 Fax: +82-54-770-8378 E-mail: ktokhou@gmail.com Posterior reversible encephalopathy syndrome (PRES), also named reversible posterior leukoencephalopathy, is not a familiar term to neurosurgeon. The PRES is characterized by various kinds of neurologic signs and symptoms that include headache, seizure, altered mental status, lethalgy, visual loss and focal neurological disability. A 63-year-old female visited with upper back pain and both leg weakness. She has been receiving chemotherapy with gemcitabine and cisplatin for lung cancer with multiple bone metastasis. According to the imaging, we diagnosed the patient as T8 pathologic fracture. Five days after surgical decompression, she suddenly complained of visual loss. Magnetic resonance imaging(MRI) of the brain showed bilateral subcortical and cortical edema in the parieto-occipital area. Her MRI finding and symptoms suggested the PRES. Five days after conservative treatment, her visual disturbance was completely recovered. We believe that accurate and early detection of PRES and adequate treatment is very important for the patient having a history of chemotherapy.